Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Circulation

• Publication date

  2001-11-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HC4501.098468PMID 11696481
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Paraoxonase and coronary heart disease.

  2002cited by this paper
• Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I

  2001cited by this paper
• Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor

  2001cited by this paper
• A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport

  2001cited by this paper
• Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I.

  2001cited by this paper
• Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II

  2001cited by this paper
• High-Dose Recombinant Apolipoprotein A-IMilano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E-Deficient Mice: Potential Implications for Acute Plaque Stabilization

  2001cited by this paper
• Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters.

  2000cited by this paper
• Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1.

  2000cited by this paper
• Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport.

  2000cited by this paper
• Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.

  2000cited by this paper
• CETP and atherosclerosis.

  2000cited by this paper
• Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty.

  2000cited by this paper
• An Absorbing Study of Cholesterol

  2000cited by this paper
• ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins.

  2000cited by this paper
• Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

  2000cited by this paper
• Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease.

  2000cited by this paper
• Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse.

  2000cited by this paper
• Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha.

  2000cited by this paper
• Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor.

  2000cited by this paper
• Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men

  2000cited by this paper
• HDL-cholesterol and the treatment of coronary heart disease: contrasting effects of atorvastatin and simvastatin.

  2000cited by this paper
• Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis

  2000cited by this paper
• ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR.

  2000cited by this paper
• A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits

  2000cited by this paper
• 1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis.

  2000cited by this paper
• Structure and function of apolipoprotein A-I and high-density lipoprotein

  2000cited by this paper
• Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages.

  1999cited by this paper
• Reverse cholesterol transport and atherosclerosis regression.

  1999cited by this paper
• Low serum paraoxonase: a risk factor for atherosclerotic disease?

  1999cited by this paper
• Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice.

  1999cited by this paper
• Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

  1999cited by this paper
• Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice.

  1999cited by this paper
• Paraoxonase genes and disease.

  1999cited by this paper
• Comparison of Class B Scavenger Receptors, CD36 and Scavenger Receptor BI (SR-BI), Shows That Both Receptors Mediate High Density Lipoprotein-Cholesteryl Ester Selective Uptake but SR-BI Exhibits a Unique Enhancement of Cholesteryl Ester Uptake*

  1999cited by this paper
• Role of ABC1 gene in cholesterol efflux and atheroprotection.

  1999cited by this paper
• Atheroprotective mechanisms of HDL.

  1999cited by this paper
• High Density Lipoproteins in Health and in Disease

  1999cited by this paper
• New perspectives on the management of low levels of high-density lipoprotein cholesterol.

  1999cited by this paper
• High Density Lipoproteins (HDL) Interrupt the Sphingosine Kinase Signaling Pathway

  1999cited by this paper
• Plaque disruption and thrombosis. Potential role of inflammation and infection.

  1999cited by this paper
• The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

  1999cited by this paper
• Does paraoxonase play a role in susceptibility to cardiovascular disease?

  1999cited by this paper
• Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

  1999cited by this paper
• Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men.

  1999cited by this paper
• Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux.

  1999cited by this paper
• Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q-->R genetic polymorphism.

  1999cited by this paper
• The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.

  1999cited by this paper
• Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice.

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• High Density Lipoproteins (HDL) and the Oxidative Hypothesis of Atherosclerosis

  1999cited by this paper
• Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.

  1999cited by this paper
• High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C.

  1999cited by this paper
• Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface.

  1999cited by this paper
• Plaque disruption and thrombosis: potential role of inflammation and infection.

  1999cited by this paper
• Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I.

  1999cited by this paper
• Atherosclerosis is an inflammatory disease

  1999cited by this paper
• Cell cholesterol efflux: integration of old and new observations provides new insights.

  1999cited by this paper
• Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation.

  1999cited by this paper
• Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred.

  1999cited by this paper
• The intrinsic factor–vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein

  1999cited by this paper
• Acute effects of intravenous infusion of ApoA1/phosphatidylcholine discs on plasma lipoproteins in humans.

  1999cited by this paper
• Inhibition of arterial thrombus formation by ApoA1 Milano.

  1999cited by this paper
• Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans.

  1999cited by this paper
• Evidence that high-density lipoprotein cholesterol is an independent predictor of acute platelet-dependent thrombus formation.

  1999cited by this paper
• Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.

  1999cited by this paper
• Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models.

  1999cited by this paper
• The antiatherogenic role of high-density lipoprotein cholesterol.

  1998cited by this paper
• Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport.

  1998cited by this paper
• Is cholesteryl ester transfer protein (CETP) deficiency atherogenic in familial hypercholesterolemia.

  1998cited by this paper
• Human serum paraoxonase.

  1998cited by this paper
• Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

  1998cited by this paper
• Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis?

  1998cited by this paper
• Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

  1998cited by this paper
• LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants

  1998cited by this paper
• Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes.

  1998cited by this paper
• Mechanistic studies of high-density lipoproteins.

  1998cited by this paper
• Lipoprotein-like phospholipid particles inhibit the smooth muscle cell cytotoxicity of lysophosphatidylcholine and platelet-activating factor.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• The response-to-retention hypothesis of atherogenesis reinforced.

  1998cited by this paper
• Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states.

  1998cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice.

  1998cited by this paper
• Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

  1998cited by this paper
• [Reverse cholesterol transport and use of transgenic mice and rabbits to reveal candidate genes for protection against atherosclerosis].

  1998cited by this paper
• Cholesterol, cholesterol lowering, and endothelial function.

  1998cited by this paper
• ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice.

  1998cited by this paper
• Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice.

  1998cited by this paper
• Calcium antagonists and cardiovascular risk in diabetes.

  1998cited by this paper
• Present concepts of coronary atherosclerosis-thrombosis, therapeutic implications and perspectives.

  1997cited by this paper
• INHIBITION OF ENDOTHELIAL CELL ADHESION MOLECULE EXPRESSION BY HIGH DENSITY LIPOPROTEINS

  1997cited by this paper
• Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevity.

  1997cited by this paper
• Coronary risk factors, endothelial function, and atherosclerosis: A review

  1997cited by this paper
• Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist.

  1997cited by this paper
• Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient mice.

  1997cited by this paper
• Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.

  1997cited by this paper
• Gene therapy for atherosclerosis

  1997cited by this paper
• Cholesteryl Ester Transfer Protein and Atherogenesis

  1997cited by this paper
• Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis.

  1997cited by this paper
• Of plaques and stones: the SR‐B1 (scavenger receptor class B, type 1)

  1997cited by this paper

• Protective effect of high-density lipoprotein in infective endocarditis patients after valve surgery

  2025cites this paper
• Multiple facets of HDLs as modifiable risk factors in stroke—the good, the bad, and the ugly

  2025cites this paper
• Short-term consequences of daily consumption of the quinoa (Chenopodium quinoa Willd.) diet in normal and diabetic rats

  2025cites this paper
• Explainable machine learning framework using visceral adiposity index to predict cardiorenal syndrome: a survey-weighted NHANES study with SHAP interpretation

  2025cites this paper
• Association between changes in high-density lipoprotein cholesterol and risk of cardiovascular disease.

  2024cites this paper
• Independent and joint associations of monocyte to high-density lipoprotein-cholesterol ratio and body mass index with cardiorenal syndrome: insights from NHANES 2003–2020

  2024cites this paper
• High-Density Lipoprotein Subclasses and Their Role in the Prevention and Treatment of Cardiovascular Disease: A Narrative Review

  2024cites this paper
• Polysaccharides from Lactarius volemus Fr. ameliorate high-fat and high-fructose diet induced metabolic disorders and intestinal barrier dysfunction.

  2024cites this paper
• COVID-19 and metabolic syndrome

  2023cites this paper
• The relationship between levels of apolipoprotein A1 and B in aqueous and serum with stage of diabetic retinopathy

  2023cites this paper
• An acidic polysaccharide from Patinopecten yessoensis skirt prevents obesity and improves gut microbiota and metabolism of mice induced by high-fat diet.

  2022cites this paper
• Peptides as Therapeutic Agents for Atherosclerosis.

  2022cites this paper
• Regulation of Apolipoprotein A-I Gene Expression in Human Macrophages by Oxidized Low-Density Lipoprotein

  2021cites this paper
• A homogeneous polysaccharide from Lycium barbarum: Structural characterizations, anti-obesity effects and impacts on gut microbiota.

  2021cites this paper
• Associations Among Daily Fish Intake, Monocyte/HDL-C Ratio, and Lifestyle in Japanese Males Aged >50: Risk Stratification of Atherosclerotic Cardiovascular Disease

  2021cites this paper
• Compared to serum triglyceride alone, the association between serum triglyceride to high-density lipoprotein cholesterol ratio and 10-year cardiovascular disease risk as determined by Framingham risk scores in a large Korean cohort.

  2021cites this paper
• OX-HDL: A Starring Role in Cardiorenal Syndrome and the Effects of Heme Oxygenase-1 Intervention

  2020cites this paper
• Effect of the insulin on the apolipoprotein a-i gene expression in human macrophages

  2020cites this paper
• Study on the biological effect of use flaxseed oil as a source of fat on the Biomarkers of experimental rats

  2020cites this paper
• Sex differences between Helicobacter pylori infection and cholesterol levels in an adult health checkup program

  2020cites this paper
• The protective effects of Salvia officinalis essential oil compared to simvastatin against hyperlipidemia, liver, and kidney injuries in mice submitted to a high-fat diet.

  2020cites this paper
• Hypolipidemic effects of barley-β-glucan in experimentally induced hyperlipidemic rats

  2019cites this paper
• Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis

  2019cites this paper
• To study vascular cell adhesion molecule-1 and remnant lipoprotein cholesterol in diabetes mellitus without retinopathy

  2019cites this paper
• Coronary Artery Disease The Association between Monocyte HDLC Ratio and SYNTAX Score and SYNTAX Score II in STEMI Patients Treated with Primary PCI

  2018cites this paper
• Protein Corona Formed from Different Blood Plasma Proteins Affects the Colloidal Stability of Nanoparticles Differently.

  2018cites this paper
• Hippophae rhamnoides as novel phytogenic feed additive for broiler chickens at high altitude cold desert

  2018cites this paper
• Phytochemical Screening and Antidiabetic, Antihyperlipidemic, and Antioxidant Properties of Anthyllis henoniana (Coss.) Flowers Extracts in an Alloxan-Induced Rats Model of Diabetes

  2018influential citation
• Sulfated polysaccharides from pacific abalone reduce diet-induced obesity by modulating the gut microbiota

  2018cites this paper
• APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe-/- atherosclerotic mice.

  2018cites this paper
• THE EFFECTS OF A LOW-CARBOHYDRATE HIGH-FAT DIET AND PHYSICAL EXERCISE ON TYPE 2 DIABETIC PATIENTS: A REVIEW

  2018cites this paper
• Increased triglyceride/high-density lipoprotein cholesterol ratio may be associated with reduction in the low-density lipoprotein particle size: assessment of atherosclerotic cardiovascular disease risk

  2018cites this paper
• The Association between Monocyte HDL-C Ratio and SYNTAX Score and SYNTAX Score II in STEMI Patients Treated with Primary PCI.

  2018cites this paper
• Heart Transplantation and Risk of Cardiac Vasculopathy Development: What Factors Are Important?

  2017cites this paper
• Hovenia Dulcis Extract Reduces Lipid Accumulation in Oleic Acid‐Induced Steatosis of Hep G2 Cells via Activation of AMPK and PPARα/CPT‐1 Pathway and in Acute Hyperlipidemia Mouse Model

  2017cites this paper
• Cholesterol-lowering effects of piceatannol, a stilbene from wine, using untargeted metabolomics

  2017cites this paper
• Potential serum biomarkers associated with mild and severe leptospirosis infection: A cohort study in the Malaysian population

  2017cites this paper
• High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease.

  2017cites this paper
• The Relationship between the Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Metabolic Syndrome

  2017cites this paper
• Short sleep duration is associated with B-type natriuretic peptide levels and predicts the death of Japanese patients with type 2 diabetes.

  2017cites this paper
• Nontraditional Lipid Variables Predict Recurrent Brain Ischemia in Embolic Stroke of Undetermined Source.

  2017cites this paper
• Differential expression of osteopontin, and osteoprotegerin mRNA in epicardial adipose tissue between patients with severe coronary artery disease and aortic valvular stenosis: association with HDL subclasses

  2017cites this paper
• therothrombosis and High-Risk Plaque art I : Evolving Concepts

  2016cites this paper
• High-density lipoprotein, mitochondrial dysfunction and cell survival mechanisms.

  2016cites this paper
• Petri Kresanov – Oxidized HDL lipids and the risk for atherosclerosis

  2016cites this paper
• Insulinomimetic, Antihyperlipidemic and Antioxidative Properties of Azadirachta indica. Possible Mechanism of Action

  2016cites this paper
• The short-term influence of a Mediterranean-type diet and mild exercise with and without red wine on patients with the metabolic syndrome.

  2016cites this paper
• Effects of n-3 polyunsaturated fatty acids high fat diet intervention on the synthesis of hepatic high-density lipoprotein cholesterol in obesity-insulin resistance rats

  2016cites this paper
• WITHDRAWN: Hypocholesterolemic Effects of diets supplemented with Kishk, as an Egyptian ethnic food

  2016cites this paper
• Interactions of Six SNPs in ABCA1gene and Obesity in Low HDL-C Disease in Kazakh of China

  2016cites this paper
• Pathophysiology of Myocardial Infarction

  2016cites this paper
• Hypocholesterolemic effects of diets containing different levels of kishk as a dried fermented milk–whole wheat mixture in experimental rats

  2016cites this paper
• An unusual presentation of LCAT deficiency as nephrotic syndrome with normal serum HDL-C level

  2016cites this paper
• Associations of Cholesteryl Ester Transfer Protein TaqIB Polymorphism with the Composite Ischemic Cardiovascular Disease Risk and HDL-C Concentrations: A Meta-Analysis

  2016cites this paper
• High-density lipoprotein cholesterol (HDL-C) in cardiovascular disease: effect of exercise training

  2016cites this paper
• Emerging risk factors and outcome predictors of coronary artery disease in a Sri Lankan population

  2015cites this paper
• Lack of Association between High-Density Lipoprotein Cholesterol and Angiographic Coronary Lesion Severity in Chinese Patients with Low Background Low-Density Lipoprotein Cholesterol.

  2015cites this paper
• Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.

  2015cites this paper
• Effects of ApoA-I Mimetic Peptide L-4F in LPS-Mediated Inflammation

  2015cites this paper
• Epidemiologic Characteristics of Dyslipidemia in Korea

  2015cites this paper
• Protective role of flaxseed oil on hypercholesterolemic rats

  2015cites this paper
• HYPOLIPEDEMIC EFFECT OF VARIOUS EXTRACTS OF WHOLE PLANT OF CALYCOPTERIS FLORIBUNDA (LAM) IN RAT FED WITH HIGH FAT DIET

  2015cites this paper
• A Prospective Cohort Study on Predictive Risk Factors Causing Metabolic Syndrome within the First Two Years

  2015cites this paper
• enfermedad vascular cerebral en el Hospital Ángeles Pedregal: factores de riesgo cardiovascular y pronóstico hospitalario

  2015cites this paper
• Learning from biology: synthetic lipoproteins for drug delivery.

  2015cites this paper
• HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis

  2015cites this paper
• Functional status of vascular endothelium in diabetes mellitus.

  2014cites this paper
• Low-Density Lipoprotein-Cholesterol-Induced Endothelial Dysfunction and Oxidative Stress: The Role of Statins

  2014cites this paper
• Association between Apolipoprotein B/Apolipoprotein A-1 and arterial stiffness in metabolic syndrome.

  2014cites this paper
• Portulaca oleracea reduces triglyceridemia, cholesterolemia, and improves lecithin: cholesterol acyltransferase activity in rats fed enriched-cholesterol diet.

  2014cites this paper
• Lipoproteins, stroke and statins.

  2014cites this paper
• Subfractions and subpopulations of HDL: an update.

  2014cites this paper
• A Review on the Traditional Chinese Medicinal Herbs and Formulae with Hypolipidemic Effect

  2014cites this paper
• Effect of Aerobic Exercise on Risk Factors of Cardiovascular Disease and the Apolipoprotein B / Apolipoprotein A-1 Ratio in Obese Woman

  2014cites this paper
• HDL quality and functionality: what can proteins and genes predict?

  2014cites this paper
• Atherosclerotic Plaque Imaging for Evaluation of HDL Targeting Therapy

  2014cites this paper
• Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.

  2014cites this paper
• Physical Exercise is More Effective than HRT in Improving Lipid Profile Status in Postmenopausal Women

  2014cites this paper
• Risk of cardiovascular disease is suppressed by dietary supplementation with protamine and chitooligosaccharide in Sprague-Dawley rats.

  2013cites this paper
• High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease1

  2013cites this paper
• Dyslipidemia and diabetic retinopathy.

  2013cites this paper
• Total Lipid Management and Cardiovascular Disease in the Dyslipidemia International Study

  2013cites this paper
• Statins and primary prevention of cardiovascular diseases: is there any point?

  2013cites this paper
• Low dietary folate and methylenetetrahydrofolate reductase deficiency may lead to pregnancy complications through modulation of ApoAI and IFN-γ in spleen and placenta, and through reduction of methylation potential.

  2013cites this paper
• Antioxidant activity of melatonin in diabetes in relation to the regulation and levels of plasma Cu, Zn, Fe, Mn, and Se in Zucker diabetic fatty rats.

  2013cites this paper
• Obesity and High-density lipoprotein Cholesterol (HDL-C) : The Recent Related Research Trend Including New Generation Drugs for HDL-C

  2013cites this paper
• Why Targeting HDL Should Work as a Therapeutic Tool, but Has Not

  2013cites this paper
• Melatonin ameliorates low‐grade inflammation and oxidative stress in young Zucker diabetic fatty rats

  2013cites this paper
• Association of atherosclerosis-related markers and its relationship to n-3 polyunsaturated fatty acids levels with a prevalence of coronary artery disease in an urban area in Japan

  2013cites this paper
• THE EFFECTS OF HELICOBACTER PYLORI ERADICATION IN BLOOD LEVEL OF BIOCHEMICAL PARAMETERS RELATED TO CORONARY HEART DISEASES

  2013cites this paper
• Prevalence of persistent lipid abnormalities in statin-treated patients: Belgian results of the Dyslipidaemia International Study (DYSIS)

  2013cites this paper
• Bioactive Constituents from “Triguero” Asparagus Improve the Plasma Lipid Profile and Liver Antioxidant Status in Hypercholesterolemic Rats

  2013cites this paper
• Fat Depots, Free Fatty Acids, and Dyslipidemia

  2013cites this paper
• PhD Thesis Abstract

  2013cites this paper
• Regulation of adipocyte autophagy — The potential anti-obesity mechanism of high density lipoprotein and ApolipoproteinA-I

  2012cites this paper
• Serum Apolipoproteins Are Associated With Systemic and Retinal Microvascular Function in People With Diabetes

  2012cites this paper
• Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada

  2012cites this paper
• Novel therapeutic approaches to prevention and regression of atherosclerosis

  2012cites this paper
• Consistency of Extended-Release Niacin/Laropiprant Effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 Ratio Across Patient Subgroups

  2012cites this paper
• Plant‐Derived Manufacturing of Apolipoprotein AIMilano: Purification and Functional Characterization

  2012cites this paper